The goal of this study is to evaluate the effects of opioid antagonists on the hypothalamic-pituitary-gonadal axis in subjects with idiopathic hypogonadotropic hypogonadism (HH).
Assignment: Each study subject will serve as their own control.
Delivery of Interventions:
| Condition | Hypogonadotropic Hypogonadism |
|---|---|
| Treatment | GnRH, naloxone, kisspeptin, GnRH, naloxone |
| Clinical Study Identifier | NCT04975334 |
| Sponsor | Stephanie B. Seminara, MD |
| Last Modified on | 3 April 2023 |
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteer
Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!
No annotations made yet
Congrats! You have your own personal workspace now.